H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Oseltamivir-resistant influenza A virus potentially serious to high-risk patients

Oseltamivir-resistant influenza A virus potentially serious to high-risk patients

Scientists identify lab-made proteins that neutralize a broad range of influenza A viruses

Scientists identify lab-made proteins that neutralize a broad range of influenza A viruses

Scientists identify lab-made proteins that neutralize multiple strains of seasonal and pandemic flu

Scientists identify lab-made proteins that neutralize multiple strains of seasonal and pandemic flu

Scientists identify human monoclonal antibodies effective against bird flu

Scientists identify human monoclonal antibodies effective against bird flu

GlaxoSmithKline ready to supply Biota's Relenza to meet CDC recommendations

GlaxoSmithKline ready to supply Biota's Relenza to meet CDC recommendations

Novavax announces positive results in trial of seasonal influenza VLP (trivalent) vaccine candidate

Novavax announces positive results in trial of seasonal influenza VLP (trivalent) vaccine candidate

High dose flu vaccine boosts immune response in elderly

High dose flu vaccine boosts immune response in elderly

Universal vaccine could protect people and pets from deadly flu pandemics

Universal vaccine could protect people and pets from deadly flu pandemics

Bird flu pandemic would require multi-drug approach

Bird flu pandemic would require multi-drug approach

WHO warns Aussies to prepare for deadly flu

WHO warns Aussies to prepare for deadly flu

Research helps explain why some flu strains cause major pandemics and others lead to seasonal epidemics

Research helps explain why some flu strains cause major pandemics and others lead to seasonal epidemics

Evolutionary analysis of influenza viruses

Evolutionary analysis of influenza viruses

Oseltamivir resistance in European Influenza viruses

Oseltamivir resistance in European Influenza viruses

Seasonal flu levels trigger use of antiviral drugs

Seasonal flu levels trigger use of antiviral drugs

Nanoviricide drug candidate effectiveness confirmed against rabies and influenzas

Nanoviricide drug candidate effectiveness confirmed against rabies and influenzas

Key differences discovered between avian and human flu

Key differences discovered between avian and human flu

Sanofi pasteur ships doses of Fluzone influenza vaccine for the 2007-2008 season

Sanofi pasteur ships doses of Fluzone influenza vaccine for the 2007-2008 season

Tamiflu could halve the pandemic influenza death toll versus no intervention

Tamiflu could halve the pandemic influenza death toll versus no intervention

H5N1 influenza virus survivors' antibodies effective at neutralising H5N1 strain

H5N1 influenza virus survivors' antibodies effective at neutralising H5N1 strain

LigoCyte Pharmaceuticals presents data showing that immunization with their influenza H1N1-VLP formulation resulted in 100% protection from H1N1 and H3N2

LigoCyte Pharmaceuticals presents data showing that immunization with their influenza H1N1-VLP formulation resulted in 100% protection from H1N1 and H3N2